Researchers at the Shi Lab have discovered a first-in-class LSD1 PROTAC degrader, which opens up new therapeutic paths for the treatment of acute myeloid leukaemia. PROTAC degraders are molecules that degrade proteins by using the cell\u2019s own machinery, binding to both the target protein and an E3 ligase, which marks it for degradation by the proteasome.
The University honoured remarkable talent and dedication to excellence on Thursday 15 May as the winners of the Vice-Chancellor's Awards 2025 were announced. Congratulations to Dr Joshua Bull from the Mathematical Institute, who received the Breakthrough Researcher Award.
The National Academy of Sciences (NAS) in the US just announced the election of 120 members and 30 international members in recognition of their distinguished and continuing achievements in original research. Election to membership in the NAS is a mark of excellence in science and considered one of the highest honours that a scientist can receive.
Researchers and clinicians have developed major new guidelines for the monitoring of patients with inflammatory bowel disease (IBD) to prevent them going on to develop bowel cancer.
Together with the CRIS Cancer Foundation, Oxford Cancer has launched the CRIS Cancer Clinical Career Fellow Award 2025, a new opportunity for clinical academics aiming to integrate cancer research with medical practice. Designed to foster independent research careers, this fellowship offers funding of up to \u00a374,600 annually for up to three years to support salaries, research expenses, and clinical activities.
A new study led by the University of Oxford has revealed that a common and usually harmless virus may positively influence how skin cancer patients respond to current treatments.
A joint event from the Centre for Personalised Medicine (CPM) & Oxford Centre for Cancer Early Detection and Prevention (OxCODE) on Monday 2nd June 2025.
Dr Karthik Ramasamy and team will assess a new mass spectrometry-based monitoring technique for its ability to predict and identify early disease relapse.
Cancer Research UK and partners have today committed \u00a35.5m in funding to form a world-leading research team tasked with making personalised medicine a reality for people with bowel cancer. The team will be co-led by Professor Simon Leedham from the Nuffield Department of Medicine at the University of Oxford.
The DPhil in Cancer Science is inviting PIs from across Oxford University\u2019s medical, physical, engineering, data, and mathematical sciences to submit their project ideas for its 2026 intake.
A study led by researchers from Oxford Population Health has found that daily physical activity is linked to a lower risk of cancer. The number of steps taken daily may be more important for cancer risk than the intensity of activity.
The 12th Annual Oxford Cancer Symposium, supported by the CRUK Oxford Centre, took place this year on the 18th March at the University's Mathematical Institute.
From 2025, Cancer Research UK (CRUK) will require all new wet-lab grant applications to have sustainability accreditation. Join the Laboratory Efficiency Assessment Framework (LEAF) now for support in meeting these new requirements!
Dr Karin Hellner is awarded a CRUK Biology to Prevention grant to undertake pre-clinical research into a broad-coverage vaccine to treat chronic human papillomavirus infection.
Researchers from around the UK, led by the University of Oxford, have found that a new way of performing prostate biopsies is better at diagnosing prostate cancer, but takes longer to perform and is more painful for patients.
Genomic testing and targeted therapies for patients with advanced cancer could improve survival rates by up to 40%, according to researchers at the Norfolk and Norwich University Hospital, University of Adelaide and University of Oxford.
Ludwig Oxford\u2019s Parinaz Mehdipour has been awarded a CRUK Early Detection and Diagnosis Primer to identify circular RNA biomarkers for the early detection of normal colon cell transformation into precancerous and colorectal cancer states
![\"\"](\"https://www.cancer.ox.ac.uk/news/oxford-cancer-hosts-the-inaugural-oxford-liver-cancer-centre-of-excellence-symposium/responsive_image?ratio=r16x9&scale=w760\")
\n \n \n\n\n